Transdermal buprenorphine controls central neuropathic pain.

Author: GordonEva, SarantopoulosConstantine, WeinerMichelle

Paper Details 
Original Abstract of the Article :
A 53-year-old male with peripheral sensorimotor neuropathy suffered an intracerebral hemorrhage resulting in right hemiparesis and hemisensory loss. Three months later, he developed constant and burning pain within the entire right side of his body. He was diagnosed with central pain syndrome and tr...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.5055/jom.2012.0141

データ提供:米国国立医学図書館(NLM)

Central Neuropathic Pain: A Novel Approach with Buprenorphine

The field of pain management is constantly seeking effective treatments for neuropathic pain, a challenging condition that can significantly impact quality of life. This case report explores the efficacy of transdermal buprenorphine in managing central neuropathic pain in a 53-year-old male patient. The authors describe how buprenorphine effectively controlled the patient's pain, demonstrating its potential as a treatment option when other opioids fail.

Buprenorphine: A Potential Solution for Central Neuropathic Pain

The case report's findings suggest that transdermal buprenorphine may be a promising treatment option for central neuropathic pain, particularly in cases where other opioids have proven ineffective. This information could potentially guide clinical decision-making and offer relief to patients struggling with this challenging condition.

A Beacon of Hope in the Desert of Neuropathic Pain

This case report provides a glimmer of hope for individuals suffering from central neuropathic pain. The successful use of transdermal buprenorphine in this patient offers a potential oasis in the vast desert of neuropathic pain management, suggesting a path towards improved pain control and quality of life.

Dr.Camel's Conclusion

This case report highlights the potential of transdermal buprenorphine as a promising treatment option for central neuropathic pain, particularly when other opioids fail. The successful use of buprenorphine in this patient offers a beacon of hope in the vast desert of neuropathic pain management, potentially opening a new path towards improved pain control and quality of life.

Date :
  1. Date Completed 2013-02-25
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

23264319

DOI: Digital Object Identifier

10.5055/jom.2012.0141

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.